Estudo randomizado | Em crianças com síndrome nefrótica sensível a esteroides recorrente e com infecção aguda de trato respiratório, uma baixa dose diária de prednisolona não reduz o risco de recaída.

Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial – JAMA Pediatrics

Comentário: PREDNOS 2: Prednisolone Doesn’t Lower Relapse Risks in Kids with Nephrotic Syndrome – Physician’s Weekly

Comentário no Twitter

In a large non-selected sample of children (365) with relapsing steroid sensitive nephrotic syndrome, the PREDNOS 2 RCT has shown that low dose prednisolone given for 6 days at the start of an URTI does not reduce the risk of relapse https://t.co/9271PHQh0r

— JAMA Pediatrics (@JAMAPediatrics) December 20, 2021